Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Investigate ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis

ClinicalTrials.gov ID: NCT04607980

Public ClinicalTrials.gov record NCT04607980. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 25, 2026, 11:55 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Randomized, Double-Blind Study Evaluating the Efficacy and Safety of ABP 654 Compared With Ustekinumab in Subjects With Moderate to Severe Plaque Psoriasis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the study is to evaluate the efficacy, safety, and immunogenicity of ABP 654 compared with ustekinumab in participants with moderate to severe plaque psoriasis.

Study identification

NCT ID
NCT04607980
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Amgen
Industry
Enrollment
563 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 11, 2020 (Actual)
Primary completion
Jan 13, 2022 (Actual)
Completion
Jun 3, 2022 (Actual)
Last update posted
Dec 12, 2024

2020 – 2022

United States locations

U.S. sites
34
U.S. states
18
U.S. cities
33
Facility City State ZIP Site status
Total Skin and Beauty Dermatology Center PC Birmingham Alabama 35205 —
Alliance Dermatology and Mohs Center Phoenix Arizona 85032 —
First OC Dermatology Fountain Valley California 92708 —
University Clinical Trials, Inc. San Diego California 92123 —
San Luis Dermatology and Laser Clinic - Dermatology San Luis Obispo California 93405 —
Clinical Science Institute Santa Monica California 90404 —
Unison Clinical Trials Sherman Oaks California 91403 —
Revival Research Doral Florida 33122 —
International Dermatology Research, Inc Miami Florida 33144 —
Renstar Medical Research Ocala Florida 34470 —
Moore Clinical Research Inc. Tampa Florida 33609-2230 —
NorthShore University HealthSystem Skokie Illinois 60077 —
Springfield Clinic Springfield Illinois 62703-2403 —
Dawes Fretzin Clinical Research Group, LLC Indianapolis Indiana 46250-2041 —
Epiphany Dermatology of Kansas, LLC Overland Park Kansas 66210 —
DelRicht Research Baton Rouge Louisiana 70809 —
ALLCUTIS Research, LLC. Beverly Massachusetts 01915 —
Metro Boston Clinical Partners Brighton Massachusetts 02135 —
ActivMed Practices & Research, LLC. Portsmouth New Hampshire 03801 —
Psoriasis Treatment Center of Central New Jersey East Windsor New Jersey 08520 —
Dermatology Consulting Services, PLLC High Point North Carolina 27262 —
Wilmington Dermatology Center Wilmington North Carolina 28405 —
Bexley Dermatology Research Bexley Ohio 43209-2421 —
Dermatologists of Southwest Ohio Mason Ohio 45040 —
Oregon Dermatology and Research Center Portland Oregon 97210 —
Oregon Medical Research Center Portland Oregon 97223 —
The Pennsylvania Centre for Dermatology, LLC Exton Pennsylvania 19341 —
Clinical Partners, LLC Johnston Rhode Island 02919 —
The Skin Wellness Center PC Knoxville Tennessee 37922 —
Center for Clinical Studies Cypress Texas 77433 —
Modern Research Associates Dallas Texas 75231 —
Austin Institute for Clinical Research - Dermatology Houston Texas 77056 —
Progressive Clinical Research [Texas] San Antonio Texas 78213 —
Acclaim Dermatology Sugar Land Texas 77479-2645 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 50 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04607980, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 12, 2024 · Synced Oct 25, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04607980 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →